🔗 Share this article

An underground economy for unapproved weight-loss medications is propelled by social media fitness personalities and vendors on messaging platforms, according to new investigations.

Investigational Drug Acquiring Traction Online

The experimental drug, which remains in research studies, is being promoted by social media influencers for its supposed fat-burning properties. Viewers are encouraged to contact these profiles directly for source information, while also receiving discount codes.

Thriving Commerce on Messaging Platforms

Separately, a robust market exists on messaging services, where groups with thousands of members share “before and after” images, administration instructions and claims of next-day UK delivery. Sellers market the substance there before redirecting buyers to other platforms for transactions.

Understanding Retatrutide

Retatrutide is an investigational injection developed by US drugmaker Eli Lilly. The drug targets three gut hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Preliminary studies indicate it could assist patients lose up to a quarter of their total weight. Nicknamed the “triple G”, the substance is being hailed digitally as the next Ozempic.

Healthcare Experts Express Worries

Nevertheless, doctors and chemists have cautions that the distribution of what is still an unlicensed drug in the United Kingdom is a cause for concern and could result in individuals administering substances of uncertain source.

Several experts said the demand for the experimental drug could be linked to the increasing cost of licensed weight loss treatments such as Mounjaro.

Legal Status and Implementation

Marketing the unapproved drug on social media or Telegram is illegal in the United Kingdom, as it is an unlicensed medication that cannot be marketed or distributed for human use under the Human Medicines Regulations 2012.

Several influencers attempt to sidestep the regulations by calling to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a controlled drug, but advertising and distribution can still violate pharmaceutical, marketing, and customer laws, risking fines, legal action or imprisonment.

Service Reaction and Material Elimination

According to the social media company, the service has taken down problematic material and banned associated keywords and search suggestions. The organization stated it was committed to maintaining the platform secure and investing in strengthening compliance measures.

Online Trading Activities

Investigations also found groups with up to 9,000 participants marketing retatrutide using the platform's built-in search feature, which functions like a online catalog. Typing “retatrutide” immediately displays groups with thousands of users, filled with images of slimming results, positive reviews and step-by-step guides for mixing or administering at home.

After moments of joining one group, a vendor shared WhatsApp details, where the majority of purchases occur. The seller provided an guidebook and guaranteed shipping within two days. When questioned whether the product was genuine, one seller responded: “You can’t be sure.” Another provided a photo of a alleged testing documentation. Not one inquired about weight, health issues or previous experience.

Product Details and Pricing

Inside these communities, posts display dark colored parcels with Royal Mail labels, claiming to include fresh supplies. One communication stated: “It took eight of us to load them this morning.”

Customers can choose between powder vials, mixed at home with purified liquid, or ready-to-use pens typically priced at 160 pounds for 20 milligrams. When asked how long a pen should be used, vendors give contradictory responses ranging from a few weeks to “depends on your body”.

Platform Moderation and Safety Actions

A spokesperson for the messaging service said it regularly moderated dangerous content on its service including content that encouraged the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.

Healthcare Professional Cautions

“People are injecting substances they can’t verify. Even if the research behind retatrutide is sound, these digital products may not include what they advertise,” said a pharmacy expert, the head of pharmacy at a pharmacy service.

Dr Crystal Wyllie of Asda Online Doctor linked the surge in interest to current price rises for approved slimming drugs such as Mounjaro. “With prices rising, patients are using online platforms. But fake treatments are extremely dangerous. You cannot know what’s inside or whether the conditions they were produced in was sterile,” she said.

Her staff has previously seen individuals harmed by personal administration from unverified suppliers. “We recognize the disappointment, but purchasing from messaging apps or WhatsApp is gambling with your health,” said the doctor. “These materials could be impure or improperly measured.”

Manufacturer Position

A representative from the pharmaceutical company said the substance was in third stage clinical trials and had not been evaluated or approved by any government authority anywhere in the world. “Consequently at this time no one can market [it] for human use,” they said, noting that any item “falsely representing itself as a Lilly experimental product not yet approved … may expose patients to possibly significant health risks”.